TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32658399

Group type: EXPERIMENTAL
Intervention: 2.5% sodium bicarbonate
Number of subjects: 91

Group type: COMPARATOR
Intervention: Docusate sodium
Number of subjects: 91
Study: 35933328

Group type: EXPERIMENTAL
Intervention: PENG block
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham block
Number of subjects: 60
Study: 36064729

Group type: EXPERIMENTAL
Intervention: Hip strap
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Foot orthoses
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 29
Study: 32770664

Group type: EXPERIMENTAL
Intervention: Gifting of chickens by a community champion combined with a behaviour change package of integrated poultry management and human nutrition trainings
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 36114096

Group type: EXPERIMENTAL
Intervention: Nab-paclitaxel (100 mg/m² on days 1, 8, and 15 of a 21-day cycle)
Number of subjects: 503

Group type: COMPARATOR
Intervention: Docetaxel (60 mg/m² on day 1)
Number of subjects: 503

Group type: EXPERIMENTAL
Intervention: Nab-paclitaxel
Number of subjects: 503

Group type: COMPARATOR
Intervention: Docetaxel
Number of subjects: 503
Study: 32186967

Group type: EXPERIMENTAL
Intervention: Self-hypnosis treatment program
Number of subjects: 90
Study: 34740708

Group type: EXPERIMENTAL
Intervention: Blonanserin transdermal patches (40-80 mg/day)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Blonanserin transdermal patches
Number of subjects: 155
Study: 33007780

Group type: EXPERIMENTAL
Intervention: Fluticasone furoate nasal spray (FFNS) 55 µg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fluticasone furoate nasal spray (FFNS) 110 µg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32458495

Group type: EXPERIMENTAL
Intervention: Locomotion replacement training (LRT)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Standing (STA)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 10
Study: 33752752

Group type: EXPERIMENTAL
Intervention: 5-day regimen of post-operative antibiotics
Number of subjects: 600

Group type: COMPARATOR
Intervention: 1-day regimen of post-operative antibiotics
Number of subjects: 600
Study: 35963664

Group type: EXPERIMENTAL
Intervention: CALF
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: PRI
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: DFI
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: MPRI
Number of subjects: 40
Study: 32840287

Group type: EXPERIMENTAL
Intervention: RBD-IgM
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: S-IgM
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: N-IgG
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: RBD-IgG
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: N-IgM
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: NAbs
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: S-IgG
Number of subjects: 191
Study: 35918630

Group type: EXPERIMENTAL
Intervention: Endurance training (50 min, 3x/week, intensity between 70 and 85% of maximum HR predicted for age)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Endurance training (TG)
Number of subjects: 18
Study: 33360753

Group type: EXPERIMENTAL
Intervention: Ultrasound guided percutaneous insertion
Number of subjects: 108

Group type: COMPARATOR
Intervention: Open insertion
Number of subjects: 108
Study: 616539009

Group type: EXPERIMENTAL
Intervention: Intensive peer coaching and nurse case management
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intensive peer coaching
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Brief nurse counseling
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care control treatment (including brief peer coaching and brief nurse counseling)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All interventions (including control)
Number of subjects: 0
Study: 36197309

Group type: EXPERIMENTAL
Intervention: AVT02 administered via prefilled syringe (PFS)
Number of subjects: 207

Group type: EXPERIMENTAL
Intervention: AVT02 administered via autoinjector (AI)
Number of subjects: 207

Group type: COMPARATOR
Intervention: AVT02 administered via PFS
Number of subjects: 207

Group type: COMPARATOR
Intervention: AVT02 administered via AI
Number of subjects: 207
Study: 32915370

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 64
Study: 32493411

Group type: EXPERIMENTAL
Intervention: Overall adjustment acupuncture (OA)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Sham acupuncture (SA)
Number of subjects: 104
Study: 36062569

Group type: EXPERIMENTAL
Intervention: Probiotics (4 g daily)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Metformin (1.5 g daily)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Combination of probiotics and metformin
Number of subjects: 60
Study: 34639792

Group type: EXPERIMENTAL
Intervention: Tailored cigarette warning messages (gain versus loss framing; short-term versus long-term framing)
Number of subjects: 512

Group type: EXPERIMENTAL
Intervention: Messages congruent with individual loss aversion and delay discounting rates
Number of subjects: 512

Group type: COMPARATOR
Intervention: Control group (no tailored messages)
Number of subjects: 512
Study: 32473149

Group type: EXPERIMENTAL
Intervention: Height for age z scores in the first 2 years of life
Number of subjects: 791

Group type: EXPERIMENTAL
Intervention: Change in height for age z scores between early and later childhood
Number of subjects: 791
Study: 34499273

Group type: EXPERIMENTAL
Intervention: APERS-based intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 34146697

Group type: EXPERIMENTAL
Intervention: Denosumab
Number of subjects: 7
Study: 35877037

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 33705475

Group type: EXPERIMENTAL
Intervention: Open-label placebo (OLP) plus treatment as usual (TAU)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Open-label placebo (OLP)
Number of subjects: 54
Study: 34073401

Group type: EXPERIMENTAL
Intervention: Ivermectin (single dose according to body weight)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard preventive treatment (mainly supplements)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Ivermectin
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study: 32312114

Group type: EXPERIMENTAL
Intervention: Sonothrombolysis and percutaneous coronary intervention
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control (percutaneous coronary intervention only)
Number of subjects: 100
Study: 36295487

Group type: EXPERIMENTAL
Intervention: Platelet‐rich fibrin (PRF)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Connective tissue graft (CTG)
Number of subjects: 26
Study: 33754455

Group type: EXPERIMENTAL
Intervention: Single daily dosing (0.3 mg/kg/dose)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Divided dosing (0.15 mg/kg/dose every 8 hours)
Number of subjects: 194

Group type: EXPERIMENTAL
Intervention: Both dosing strategies
Number of subjects: 194
Study: 32195801

Group type: EXPERIMENTAL
Intervention: p‐COP‐determined iodine dose (Group A, n = 65)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Standard protocol (Group B, n = 65)
Number of subjects: 130
Study: 35946167

Group type: EXPERIMENTAL
Intervention: DIALOG+ intervention
Number of subjects: 468
Study: 33706070

Group type: EXPERIMENTAL
Intervention: Menthol cigarette users
Number of subjects: 268

Group type: COMPARATOR
Intervention: Non-menthol cigarette users
Number of subjects: 268
Study: 35103587

Group type: EXPERIMENTAL
Intervention: FDC hard capsule containing CC/HCTZ/RSV
Number of subjects: 24
Study: 33622507

Group type: EXPERIMENTAL
Intervention: TCIT-U
Number of subjects: 144

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 144
Study: 36109821

Group type: EXPERIMENTAL
Intervention: 4-h online resourcefulness training
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional training (psychological training, psychological counseling)
Number of subjects: 60
Study: 32985902

Group type: EXPERIMENTAL
Intervention: Zanubrutinib plus rituximab followed by zanubrutinib monotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bendamustine plus rituximab followed by observation
Number of subjects: 0
Study: 35367015

Group type: EXPERIMENTAL
Intervention: Ovarian fragmentation for follicular activation (OFFA)
Number of subjects: 34

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 34
Study: 34016263

Group type: EXPERIMENTAL
Intervention: Liraglutide (glucagon-like peptide-1 analog) for 1 year
Number of subjects: 633

Group type: COMPARATOR
Intervention: Control subjects (not specified)
Number of subjects: 633

Group type: EXPERIMENTAL
Intervention: C16:0‐ceramide
Number of subjects: 633

Group type: EXPERIMENTAL
Intervention: C16:0‐glycosylceramide
Number of subjects: 633
Study: 32531622

Group type: EXPERIMENTAL
Intervention: Gelfoam
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Silastic sheets
Number of subjects: 78
Study: 35181293

Group type: EXPERIMENTAL
Intervention: High energy preload
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Low energy preload
Number of subjects: 66
Study: 33440999

Group type: EXPERIMENTAL
Intervention: Short SBT (≤2 hours)
Number of subjects: 3115

Group type: EXPERIMENTAL
Intervention: Long SBT (>4 hours)
Number of subjects: 3115

Group type: EXPERIMENTAL
Intervention: Intermediate SBT (2-4 hours)
Number of subjects: 3115

Group type: EXPERIMENTAL
Intervention: Intermediate DBT (45-90 minutes)
Number of subjects: 3115

Group type: EXPERIMENTAL
Intervention: Long DBT (>90 minutes)
Number of subjects: 3115
Study: 34905069

Group type: EXPERIMENTAL
Intervention: PROT + TIMING
Number of subjects: 0
Study: 32783367

Group type: EXPERIMENTAL
Intervention: GnRH agonist pretreatment (n=172)
Number of subjects: 343

Group type: COMPARATOR
Intervention: Control group (no GnRH agonist pretreatment, n=171)
Number of subjects: 343
Study: 32345077

Group type: EXPERIMENTAL
Intervention: 0.25 µg alfacalcidol daily for 12 weeks
Number of subjects: 77

Group type: COMPARATOR
Intervention: Placebo for 12 weeks
Number of subjects: 77
Study: 32154928

Group type: EXPERIMENTAL
Intervention: Bevacizumab 10 mg/kg every 2 weeks plus trebananib 15 mg/kg every week
Number of subjects: 115

Group type: COMPARATOR
Intervention: Bevacizumab plus placebo
Number of subjects: 115
Study: 35038985

Group type: EXPERIMENTAL
Intervention: In-Home Cognitive Processing Therapy (CPT)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Telehealth Cognitive Processing Therapy (CPT)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: In-Office Cognitive Processing Therapy (CPT)
Number of subjects: 120

Group type: COMPARATOR
Intervention: In-Home vs Telehealth
Number of subjects: 120

Group type: COMPARATOR
Intervention: In-Home vs Telehealth vs In-Office (Dropout rates)
Number of subjects: 120
Study: 33327240

Group type: EXPERIMENTAL
Intervention: Oral Maxing Shigan Decoction
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Oral Qingfei Decoction
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study: 35636686

Group type: EXPERIMENTAL
Intervention: Rocuronium 0.6 mg/kg
Number of subjects: 124

Group type: COMPARATOR
Intervention: Succinylcholine 1.5 mg/kg
Number of subjects: 124
Study: 33766084

Group type: EXPERIMENTAL
Intervention: Melatonin supplementation (250 mg, two tablets once a day for 8 weeks)
Number of subjects: 50
Study: 32171997

Group type: EXPERIMENTAL
Intervention: Attentional Bias Modification (ABM)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Control training
Number of subjects: 79
Study: 36131214

Group type: EXPERIMENTAL
Intervention: Oseltamivir
Number of subjects: 0
Study: 33151634

Group type: EXPERIMENTAL
Intervention: Cognitive and behavioral therapy (CBT) plus antidepressants
Number of subjects: 28
Study: 35051281

Group type: EXPERIMENTAL
Intervention: 2-year multi-domain intervention with diet, physical and cognitive activity, and vascular monitoring (n=631)
Number of subjects: 1259

Group type: COMPARATOR
Intervention: General health advice (n=628)
Number of subjects: 1259

Group type: EXPERIMENTAL
Intervention: 2-year multi-domain intervention among those with history of CVD (n=145)
Number of subjects: 1259
Study: 33746024

Group type: EXPERIMENTAL
Intervention: Dual therapy (ticagrelor 90 mg twice daily and rivaroxaban 15 mg once daily)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Triple therapy (aspirin 100 mg and clopidogrel 75 mg once daily combined with dose-adjusted warfarin)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Dual therapy (ticagrelor plus rivaroxaban)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Triple therapy (warfarin plus dual antiplatelet therapy)
Number of subjects: 106
Study: 35290512

Group type: EXPERIMENTAL
Intervention: Caregiver navigation intervention using eSNAP social resource visualization
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Caregiver navigation intervention
Number of subjects: 15
Study: 33245237

Group type: EXPERIMENTAL
Intervention: Stochastic Negative Addition (SNA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: y-randomized controls
Number of subjects: 0
Study: 35656740

Group type: EXPERIMENTAL
Intervention: Digital divorce intervention
Number of subjects: 676
Study: 32935904

Group type: EXPERIMENTAL
Intervention: Nopal fiber 20 g/day
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Nopal fiber 30 g/day
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (30 g/day dextrose)
Number of subjects: 60
Study: 32380988

Group type: EXPERIMENTAL
Intervention: 50% oxygen
Number of subjects: 68

Group type: COMPARATOR
Intervention: 21% oxygen (air)
Number of subjects: 68
Study: 35569806

Group type: EXPERIMENTAL
Intervention: Formal shared decision-making intervention
Number of subjects: 228

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 228
Study: 33241739

Group type: EXPERIMENTAL
Intervention: Role-play with booster training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Role-play without booster training
Number of subjects: 0

Group type: COMPARATOR
Intervention: No role-play with booster training
Number of subjects: 0

Group type: COMPARATOR
Intervention: No role-play without booster training
Number of subjects: 0
Study: 32682394

Group type: EXPERIMENTAL
Intervention: Early Oral Hydration (EOH) - small amount of drinking water after recovery of swallowing reflex
Number of subjects: 2000

Group type: COMPARATOR
Intervention: Delayed Oral Hydration (DOH) - water administered at 4 hours post-anesthesia
Number of subjects: 2000
Study: 35617974

Group type: EXPERIMENTAL
Intervention: Lotion
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: Cream
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: Gel
Number of subjects: 550

Group type: EXPERIMENTAL
Intervention: Ointment
Number of subjects: 550
Study: 33769510

Group type: EXPERIMENTAL
Intervention: Thrombus aspiration
Number of subjects: 10732

Group type: COMPARATOR
Intervention: PCI alone
Number of subjects: 10732
Study: 32776570

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy for ARFID (CBT-AR), 20–30 sessions delivered in family-based or individual format.
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy for ARFID (CBT-AR)
Number of subjects: 25
Study: 35485618

Group type: EXPERIMENTAL
Intervention: ATVV stimulation therapy
Number of subjects: 107

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 107
Study: 32285047

Group type: EXPERIMENTAL
Intervention: Proprietary Lactobacillus casei
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 33627250

Group type: COMPARATOR
Intervention: IMN alone (Group 1)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: IMN + 1 Poller screw (Group 2)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: IMN + 2 Poller screws (Group 3)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Control (IMN alone)
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 154
Study: 35388029

Group type: EXPERIMENTAL
Intervention: Weekly sessions of psychotherapy for 12 months
Number of subjects: 10

Group type: COMPARATOR
Intervention: Standard of care treatment
Number of subjects: 10
Study: 33496870

Group type: EXPERIMENTAL
Intervention: CTTQ
Number of subjects: 18

Group type: COMPARATOR
Intervention: Parkedale
Number of subjects: 18
Study: 32684741

Group type: EXPERIMENTAL
Intervention: Yikou-Sizi powder hot compress on Shenque acupuncture point combined with rapid rehabilitation technique
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine treatment
Number of subjects: 0
Study: 34304330

Group type: EXPERIMENTAL
Intervention: Home-based delivery (HBD)
Number of subjects: 2489

Group type: EXPERIMENTAL
Intervention: Adherence clubs (AC)
Number of subjects: 2489

Group type: COMPARATOR
Intervention: Facility-based delivery (SoC)
Number of subjects: 2489

Group type: EXPERIMENTAL
Intervention: Community models of ART delivery
Number of subjects: 2489
Study: 32991776

Group type: EXPERIMENTAL
Intervention: CIN risk score model based on LVEF < 40%, acute coronary syndrome (ACS), eGFR < 60, and contrast volume > 300 mL.
Number of subjects: 1113

Group type: EXPERIMENTAL
Intervention: CIN risk score model
Number of subjects: 1113

Group type: COMPARATOR
Intervention: Mehran score
Number of subjects: 1113
Study: 34811787

Group type: EXPERIMENTAL
Intervention: Higher threat messages
Number of subjects: 892

Group type: COMPARATOR
Intervention: Lower threat messages
Number of subjects: 892
Study: 34697566

Group type: EXPERIMENTAL
Intervention: Low-dose Betaloc (≤47.5 mg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Medium-dose Betaloc (47.5-95 mg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: High-dose Betaloc (142.5-190 mg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (No Betaloc)
Number of subjects: 60
Study: 33963005

Group type: EXPERIMENTAL
Intervention: Automated oxygen titration with the VDL1.1 algorithm
Number of subjects: 35

Group type: COMPARATOR
Intervention: Manual control
Number of subjects: 35
Study: 33597355

Group type: EXPERIMENTAL
Intervention: Fluorescence imaging with 5-aminolevulinic acid (5-ALA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: White light imaging
Number of subjects: 0
Study: 32246680

Group type: EXPERIMENTAL
Intervention: Low-Level Laser Therapy (LLLT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Transcutaneous Electric Nerve Stimulation (TENS)
Number of subjects: 60
Study: 35152918

Group type: EXPERIMENTAL
Intervention: 2 μg vitamin B12 daily for a year
Number of subjects: 600

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 600
Study: 32674594

Group type: EXPERIMENTAL
Intervention: Various treatments for COVID-19 (specific interventions not detailed)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fixed time-point methods (specific interventions not detailed)
Number of subjects: 0
Study: 34793864

Group type: EXPERIMENTAL
Intervention: Preoperative accelerated radiotherapy (AF) with 43 fractions, total dose of 68 Gy in 4.5 weeks followed by surgery
Number of subjects: 250

Group type: COMPARATOR
Intervention: Postoperative conventionally fractionated radiotherapy (CF), total dose of 60 or 66 Gy in 6-7 weeks
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Preoperative accelerated radiotherapy (AF)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Postoperative conventionally fractionated radiotherapy (CF)
Number of subjects: 250
Study: 35192788

Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT) in addition to standard medical care (SMC)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Standard medical care (SMC)
Number of subjects: 155
Study: 34444004

Group type: EXPERIMENTAL
Intervention: Immediate Treatment Group (IT, n = 10)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Waitlist Control Group (WL, n = 10)
Number of subjects: 20
Study: 32957340

Group type: EXPERIMENTAL
Intervention: Intravenous low-dose ketamine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 0
Study: 36000293

Group type: EXPERIMENTAL
Intervention: Test linezolid tablet (600 mg)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Reference linezolid tablet (600 mg)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Test and Reference linezolid tablets
Number of subjects: 48
Study: 34617684

Group type: EXPERIMENTAL
Intervention: Interactive video
Number of subjects: 558

Group type: COMPARATOR
Intervention: Combined videos (regular and interactive)
Number of subjects: 558
Study: 32206772

Group type: EXPERIMENTAL
Intervention: obinutuzumab+venetoclax (VenG)
Number of subjects: 421

Group type: COMPARATOR
Intervention: obinutuzumab+chlorambucil (GClb)
Number of subjects: 421
Study: 35627343

Group type: EXPERIMENTAL
Intervention: GeMuKi lifestyle intervention (brief counseling on nutrition and physical activity during prenatal check-ups)
Number of subjects: 0
Study: 34302417

Group type: EXPERIMENTAL
Intervention: Patient-centered transitional care model
Number of subjects: 986

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 986
Study: 33735404

Group type: EXPERIMENTAL
Intervention: Diagnosis name (AMD) in claims’ data
Number of subjects: 1400

Group type: EXPERIMENTAL
Intervention: Diagnosis name (AMD) combined with fluorescence fundus angiography and/or anti‐VEGF treatment
Number of subjects: 1400

Group type: EXPERIMENTAL
Intervention: Diagnosis name (AMD) combined with AMD treatment
Number of subjects: 1400
Study: 32928844

Group type: EXPERIMENTAL
Intervention: 2-week mindfulness-based intervention
Number of subjects: 60

Group type: COMPARATOR
Intervention: Treatment as usual (control group)
Number of subjects: 60
Study: 35085443

Group type: EXPERIMENTAL
Intervention: Online administration of the Test of Narrative Language-Second Edition (TNL-2)
Number of subjects: 357

Group type: COMPARATOR
Intervention: In-person administration of the Test of Narrative Language-Second Edition (TNL-2)
Number of subjects: 357
Study: 32422285

Group type: EXPERIMENTAL
Intervention: Topical castor oil applied to one eye, twice daily for 4 weeks
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Topical castor oil applied to one eye
Number of subjects: 26
Study: 32659755

Group type: EXPERIMENTAL
Intervention: Prophylactic AV fistula ligature
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (no immediate ligature)
Number of subjects: 28